Prognostic value of [18F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies.
Simone KrebsAudrey MauguenOnur YildirimVaios HatzoglouJasmine H FrancisLauren R SchaffIngo K MellinghoffHeiko SchöderChristian GrommesPublished in: European journal of nuclear medicine and molecular imaging (2021)
NCT02315326; https://clinicaltrials.gov/ct2/show/NCT02315326?term=NCT02315326&draw=2&rank=1.